-:


Ericksson , Oberg : Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors. Acta Oncol 30:477, 1991

Godwin JD: Carcinoid tumors: An analysis of 2837 cases. Cancer 36:560, 1975

Joensuu H et al: Treatment of metastatic carcinoid tumor with recombinant interferon-alpha. EurJ Cancer 28A1650, 1992

Kvols LK et al: Treatment of the malignant carcinoid syndrome: Evaluation of a long-acting somatostatin analogue. N Engl J Med 315:663, 1986

Moertel CG et al: Carcinoid tumor of the appendix: Treatment and prognosis. N Engl J Med 317:1699, 1987

Norheim I et al: Malignant carcinoid tumors: An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg 206:115, 1987

Perry RR, Vinik Al: Endocrine tumors of the gastrointestinal tract. Annu Rev Med 47:57, 1996

Rusniewski P et al: Treatment of the carcinoid syndrome with the long-acting somatostatin analogue lanreotide. Gut 39:279, 1996

Saini A, Waxman J: Management of carcinoid syndrome. Postgrad Med 67:506, 1991

Thorson A et al: Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart, peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis: A clinical and pathologic syndrome. Am Heart 147:795, 1954

Biesma et al: Recombinant interferon alpha-2b in patients with metastatic apudomas: Effect on tumors and tumor markers. Br J Cancer 66:850, 1992

Bloom SR, Polak JM: Glucagonoma syndrome. Am J Med 82(Suppl 5B):25, 1987

Bostwick DG et al: Expression of opioid peptides in tumors. N Engl J Med 317:1439, 1987

Gibril F et al: Somatostatin receptor scintigraphy.its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med 125:26, 1996

Gorden P et al: Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and nonneopla"Stic diseases of the gut. Ann Intern Med 110:35, 1989

Klein S et al: In vivo assessment of the metabolic alterations in glucagonoma syndrome. Metabolism 41:1171, 1992

Kreis GJ: VIPoma syndrome. Am J Med 82(Suppl 5B):37, 1987

Kvols LK et al: Treatment of metastatic islet cell carcinomas with a somatostatin analogue (SMS 201-995). Ann Intern Med 107:162, 1987

Moertel CG et al: Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozocin in the treatment of advanced islet cell carcinoma. N Engl J Med 326:519, 1992

Oberg K: Neuroendocrine gastrointestinal tumours. Ann Oncol 7:453, 1996

Vinik Al et al: Somatostatinomas, PPomas, neurotensinomas. Semin Oncol 14:263, 1987

Wynick D et al: Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors. N Engl J Med 319:605, 1988

:

  • -